Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study asks: can we stop cancer drugs sooner?

NCT ID NCT03469960

Completed Disease control Sponsor: Intergroupe Francophone de Cancerologie Thoracique Source: ClinicalTrials.gov ↗

Summary

This trial tested whether a shorter, 6-month course of immunotherapy is as effective as continuing treatment until the cancer worsens for patients with advanced lung cancer. It involved 265 patients who had already responded to initial immunotherapy. The goal was to see if stopping treatment early could reduce side effects, improve quality of life, and lower costs without compromising cancer control.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HP Hopital Tenon - Pneumologie

    Paris, 75020, France

  • AP-HP Hôpital Bichat

    Paris, France

  • Amiens - CHU

    Amiens, France

  • Angers - CHU

    Angers, 49000, France

  • Annecy - CH

    Annecy, 74374, France

  • Argenteuil -CH

    Argenteuil, 95100, France

  • Avignon - CH

    Avignon, France

  • Bordeaux - Polyclinique Nord

    Bordeaux, France

  • Boulogne - Ambroise Paré

    Boulogne-Billancourt, France

  • CH

    Cholet, France

  • CH Chambery

    Chambéry, France

  • CH Lyon Sud - Pneumologie

    Lyon, France

  • CH de Chauny

    Chauny, France

  • CH de Pontoise

    Cergy-Pontoise, France

  • CH de Villefranche - Pneumologie

    Villefranche, France

  • CHRU Grenoble

    Grenoble, France

  • CHRU de Lille

    Lille, France

  • CHRU de Tours

    Tours, France

  • CHU Nîmes

    Nîmes, France

  • CHU Toulouse

    Toulouse, France

  • CHU de Limoges

    Limoges, France

  • Caen - CHU Côte de Nacre

    Caen, 14000, France

  • Cahors - CH

    Cahors, 46000, France

  • Centre Antoine Lacassagne

    Nice, France

  • Centre Hospitalier - Pneumologie

    Le Mans, 72000, France

  • Centre René Huguenin

    Saint-Cloud, France

  • Clamart - Hôpital Percy

    Clamart, 92140, France

  • Clermont Ferrand - CHU

    Clermont-Ferrand, 63000, France

  • Colmar - CH

    Colmar, 68000, France

  • Dijon - CAC

    Dijon, 21000, France

  • GH Paris Saint-Joseph

    Paris, France

  • HIA Begin

    Saint-Mandé, France

  • Hôpital Saint Louis APHP

    Paris, France

  • ICL Lucien Neuwirth

    Saint-Priest-en-Jarez, France

  • Institut Paoli Calmette

    Marseille, France

  • La Roche Sur Yon - CH

    La Roche-sur-Yon, 85925, France

  • Marseille - Hôpital Européen

    Marseille, France

  • Mont de Marsan - CH

    Mont-de-Marsan, 40000, France

  • Mulhouse - CH

    Mulhouse, 68000, France

  • Nantes - Centre René Gauducheau

    Nantes, 44805, France

  • Orléans - CH

    Orléans, 45000, France

  • Paris - Institut Curie

    Paris, France

  • Rouen - CHU

    Rouen, 76000, France

  • Saint Quentin - CH

    Saint-Quentin, 02100, France

  • Suresnes - Hopital Foch

    Suresnes, 92151, France

  • Toulon - CHI

    Toulon, 83000, France

  • Versailles - CH

    Versailles, 78157, France

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER METASTATIC